Cargando…

Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a life-threatening complication of connective tissue diseases (CTDs) characterised by increased pulmonary arterial pressure and pulmonary vascular resistance. CTD-PAH is the result of a complex interplay among endothelial dysfunction and vascular remodelling,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moccaldi, Beatrice, De Michieli, Laura, Binda, Marco, Famoso, Giulia, Depascale, Roberto, Perazzolo Marra, Martina, Doria, Andrea, Zanatta, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967966/ https://www.ncbi.nlm.nih.gov/pubmed/36835590 http://dx.doi.org/10.3390/ijms24044178

Ejemplares similares

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review of the Most Updated Literature
por: Faccioli, Eleonora, et al.
Publicado: (2022)

Left atrial expansion index measured with cardiovascular magnetic resonance estimates pulmonary capillary wedge pressure in dilated cardiomyopathy
por: Genovese, Davide, et al.
Publicado: (2023)

Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2018)

Biomarkers in Pulmonary Arterial Hypertension
por: Hojda, Silvana Elena, et al.
Publicado: (2022)

Serum Caveolin-1 as a Novel Biomarker in Idiopathic Pulmonary Artery Hypertension
por: Wang, Kuo-Yang, et al.
Publicado: (2015)

Potential mechanisms and serum biomarkers involved in sex differences in pulmonary arterial hypertension
por: Li, Chan, et al.
Publicado: (2020)

Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
por: Rice, Lisa M., et al.
Publicado: (2022)

Novel biomarkers for pulmonary arterial hypertension
por: Anwar, Anjum, et al.
Publicado: (2016)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

Cardiac Magnetic Resonance—Detected Acute Myocardial Edema as Predictor of Favourable Prognosis: A Comprehensive Review
por: Sinigiani, Giulio, et al.
Publicado: (2023)

Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls
por: De Michieli, Laura, et al.
Publicado: (2023)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertension
por: Minai, Omar A.
Publicado: (2014)

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients
por: Cavagna, Lorenzo, et al.
Publicado: (2016)

Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics
por: Jin, Nan, et al.
Publicado: (2023)

Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs)
por: Bellan, Mattia, et al.
Publicado: (2021)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient
por: De Gaspari, Monica, et al.
Publicado: (2023)

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders
por: Bellan, Mattia, et al.
Publicado: (2019)

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases
por: Bellan, Mattia, et al.
Publicado: (2022)

The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease
por: Xiong, Jiangbiao, et al.
Publicado: (2022)

Role of cardiac magnetic resonance in patients with chest pain and pulmonary aneurysm
por: China, Paolo, et al.
Publicado: (2011)

Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: a literature review
por: Depascale, Roberto, et al.
Publicado: (2021)

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
por: Grünig, Ekkehard, et al.
Publicado: (2012)

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
por: Gaine, Sean, et al.
Publicado: (2017)

The role of cardiopulmonary exercise tests in pulmonary arterial hypertension
por: Farina, Stefania, et al.
Publicado: (2018)

Novel biomarkers for risk stratification in pulmonary arterial hypertension
por: Zelniker, Thomas, et al.
Publicado: (2015)

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
por: Xanthouli, Panagiota, et al.
Publicado: (2021)

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension
por: Dong, Xingbei, et al.
Publicado: (2022)

Multiparametric analysis of coronary flow in psoriasis using a coronary flow reserve companion
por: Tona, Francesco, et al.
Publicado: (2021)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
por: Smukowska-Gorynia, Anna, et al.
Publicado: (2023)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
por: Di Benedetto, Paola, et al.
Publicado: (2020)

Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)

Biomarkers for Pediatric Pulmonary Arterial Hypertension – A Call to Collaborate
por: Colvin, Kelley L., et al.
Publicado: (2014)

Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis
por: Sun, Qian, et al.
Publicado: (2020)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Apical ballooning with mid-ventricular obstruction: the many faces of Takotsubo cardiomyopathy
por: Spadotto, Veronica, et al.
Publicado: (2013)

Circulating Cell Biomarkers in Pulmonary Arterial Hypertension: Relationship with Clinical Heterogeneity and Therapeutic Response
por: Tura-Ceide, Olga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0hl010484qnb0oeqk5hkh064r1